Research News and Research

RSS

MSF calls on drug companies to pool HIV patents

Medecins Sans Frontieres (MSF) recently launched an e-mail campaign calling on nine of the world's largest pharmaceutical companies to "release their patents on specific HIV drugs into a collective pool that will increase access and affordability to treatment in developing countries," Inter Press Service reports (Borde, 10/1).

5 Oct 2009

Uncontrolled maternal asthma during pregnancy increases the likelihood of the child developing asthma

Expectant mothers who eschew asthma treatment during pregnancy heighten the risk transmitting the condition to their offspring, according to one of the largest studies of its kind published in the European Respiratory Journal.

5 Oct 2009

NC State researchers help design affordable sanitary pads from local, organic materials

For most American women, their "time of the month" is seen as a hindrance to daily life. In impoverished and developing countries, however, monthly periods are a major cause for concern among women. The lack of affordable, quality sanitary pads results in females missing up to 50 days of school annually - thereby compromising their educational and professional potential.

5 Oct 2009

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.

5 Oct 2009

Bristol-Myers Squibb and AstraZeneca receive marketing authorisation for ONGLYZA in Europe

Bristol-Myers Squibb Company and AstraZeneca announced today that the European Commission has granted marketing authorisation for ONGLYZATM in the 27 countries of the European Union.

5 Oct 2009

Challenges surround the calculation of costs associated with illegal immigrant care

PhillyBurbs.com examines the cost of caring for undocumented immigrants and whether it really is cheaper to exclude them under a health care overhaul. Despite widespread support for requiring people to prove their citizenship to receive government health benefits, PhillyBurbs.com reports: "Public health and immigration experts worry excluding undocumented immigrants would put everyone at risk, hamper attempts to prevent the spread of disease and lead to an increase in health care spending."

5 Oct 2009

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

Las Vegas-based Endogenous Stem Cells Activators Inc. (ESAI) announced today that it will award a $1.3 million grant to Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LABioMed) for pre-clinical studies aimed at activating penile endogenous (adult) stem cells with the company's drug, KRONOS IV.

5 Oct 2009

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.

5 Oct 2009

Lawmakers plan to finance health reform with Medicare cuts, much to seniors' dismay

Lawmakers are planning to pay for much of their plans to expand coverage to the uninsured by slowing Medicare spending by as much as $500 billion over 10 years, Long Island Newsday reports. Democrats say the only thing the cuts "take out of Medicare is waste" - in the words of Senate Majority Leader Harry Reid, - but Republicans who oppose the Democrat-led reform effort have warned that cuts will reduce services for seniors.

5 Oct 2009

Sonora Medical Systems sold to Medical Imaging Holdings for $8 million

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.

5 Oct 2009

Nursing home industry: New funding cuts will force closures

"The nation's nursing homes are perilously close to laying off workers, cutting services — possibly even closing — because of a perfect storm wallop from the recession and deep federal and state government spending cuts, industry experts say," The Associated Press reports.

5 Oct 2009

Bon-Ton Stores to conduct “Shop for a Cure” event to support breast cancer research

The Bon-Ton Stores, Inc. announced today the official kick-off to National Breast Cancer Awareness Month with special promotions to support breast cancer research. On Wednesday, October 7, Bon-Ton will hold a “Shop for a Cure” one-day shopping event. The Company will donate 1% of all purchases made on its proprietary credit card on October 7 to fund breast cancer research.

5 Oct 2009

Arrayit deploys new proteomics platform

Arrayit Corporation, a life sciences and health care technology innovator, announces that on October 1st, 2009, the company deployed its next-generation proteomics platform to customers working in the areas of proteomics and in vitro molecular diagnostics.

5 Oct 2009

Majority of Americans believe they are well-protected from H1N1

A new Harris poll, commissioned by SCA Tissue North America’s Tork® brand, reveals that 74 percent of U.S. adults say it is unlikely they will contract H1N1 this year.

5 Oct 2009

QuadraMed announces the launch of its ICD-10 Countdown Program

QuadraMed® Corporation, a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced the launch of its ICD-10 Countdown Program. This new program includes the Quantim® ICD-10 Coding Simulator software, ICD-10 educational tools and services to guide healthcare providers through the ICD-10 conversion.

5 Oct 2009

Biochemics signs research collaboration agreement with Unilever

BioChemics, Inc. a company “enhancing drug delivery through biophysical modulation,” is pleased to announce the signing of a research collaboration agreement with Unilever, one of the world’s largest consumer goods companies, to utilize BioChemics’ proprietary topical delivery technology for the delivery of Unilever’s compounds.

5 Oct 2009

Pharmacogenomics Centre deploys the Isilon IQ to accelerate its next-generation genetic sequencing operations

Isilon® Systems (Nasdaq: ISLN), the proven leader in scale-out NAS, today announced that Pharmacogenomics Centre, a partnership between Genome Quebec and the Montreal Heart Institute focused on enhancing new and existing drug development research programs through the inclusion of genetic information, has deployed Isilon IQ to accelerate its next-generation genetic sequencing operations.

5 Oct 2009

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.

5 Oct 2009

New technique for tracing ultra-fine particles

Limit values for fine dust emissions are based on total particle weight. It is the ultra-fine particles, however, that are particularly harmful to health. A new technique separates them by size and identifies their composition - directly where they arise.

5 Oct 2009

Jefferies expands its global Healthcare Investment Banking Group

Jefferies today announced the expansion of its global Healthcare Investment Banking Group with the hiring of five senior professionals. Henry Elphick, Tommy Erdei and Probir Rao join as Managing Directors, Gil Bar-Nahum as a Senior Vice President, and Andrew Clayton as a Vice President. Henry Elphick, Tommy Erdei and Gil Bar-Nahum are based in London, Probir Rao is based in Mumbai, and Andrew Clayton in Hong Kong.

5 Oct 2009

Research News and Research

MSF calls on drug companies to pool HIV patents

Uncontrolled maternal asthma during pregnancy increases the likelihood of the child developing asthma

NC State researchers help design affordable sanitary pads from local, organic materials

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

Bristol-Myers Squibb and AstraZeneca receive marketing authorisation for ONGLYZA in Europe

Challenges surround the calculation of costs associated with illegal immigrant care

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

Lawmakers plan to finance health reform with Medicare cuts, much to seniors' dismay

Sonora Medical Systems sold to Medical Imaging Holdings for $8 million

Nursing home industry: New funding cuts will force closures

Bon-Ton Stores to conduct “Shop for a Cure” event to support breast cancer research

Arrayit deploys new proteomics platform

Majority of Americans believe they are well-protected from H1N1

QuadraMed announces the launch of its ICD-10 Countdown Program

Biochemics signs research collaboration agreement with Unilever

Pharmacogenomics Centre deploys the Isilon IQ to accelerate its next-generation genetic sequencing operations

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

New technique for tracing ultra-fine particles

Jefferies expands its global Healthcare Investment Banking Group

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News